CD4+CD25+ T cells as key regulators of immune responses

European Journal of Dermatology

Volumn 13, Issue 2, 2003, Pages 111-116

  Dubois, Bertrand ^a   Chapat, Ludivine ^a   Goubier, Anne ^a   Kaiserlian, Dominique ^a  

^a INSERM   (France)

Author keywords

CD4+CD25+; Inflammation; Regulatory cells; Suppression

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL MIGRATION; CONTACT SENSITIVITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LANGERHANS CELL; LYMPHATIC DRAINAGE; LYMPHOCYTE ACTIVATION; ONTOGENY; PATHOPHYSIOLOGY; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE; VACCINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DERMATITIS, CONTACT; HUMANS; IMMUNITY; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 0037357995     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387-96.
2. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
3. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4 + CD25 + suppressor T cells. Immunol Rev 2001; 182: 58-67.
4. Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25 + CD4 + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211-8.
5. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999; 59: 3128-33.
6. Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823-32.
7. Thornton AM, Shevach EM. Suppressor effector function of CD4 + CD25 + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-90.
8. Levings MK, Sangregorio R, Roncarolo MG. Human CD25 + CD25 + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of functian. J Exp Med 2001, 193: 1295-302.
9. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4 + CD25 + suppressor T cells in vivo. Nat Immunol 2002; 3: 33-41.
10. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 2001; 167: 4245-53.
11. Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25 + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167: 188-95.
12. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3: 756-63.
13. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-42.
14. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-beta in the generation and exponsion of CD4 + CD25 + regulatory T cells from human peripheral blood. J Immunol 2001; 166: 7282-9.
15. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-beta-Producing Regulatory T Cells from CD4(+)CD25(-) Precursors. J Immunol 2002; 169: 4183-9.
16. Jonuleit H, Schmitt E, Schuler G, Knop J,. Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatary properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213-22.
17. Geissmann F, Dieu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M, Brousse N, Saeland S, Davoust J. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002; 196: 417-30.
18. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-31.
19. Krasteva M, Kehren J, Horand F, Akiba H, Choquet G, Ducluzeau MT, Tedone R, Garrigue JL, Kaiserlian D, Nicolas JF. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 1998; 160: 1181-90.
20. Thornton AM, Shevach EM. CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-96.
21. Piccirillo CA, Shevach EM. Cutting edge: control of CD8 + T cell activation by CD4 + CD25 + immunoregulatory cells. J Immunol 2001; 167: 1137-40.
22. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194: 629-44.
23. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4 + CD25 + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-8.
24. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847-53.
25. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 1126-32.
26. Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, Waldmann H. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002; 168: 1069-79.
27. McHugh RS, Whitters MJ, Piccirillo CA, Young DA Shevach EM, Collins M, Byrne MC. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311-23.
28. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, Brunner M, Scheffald A, Hamann A. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25 + as well as CD25 - regulatory T cells. Proc Natl Acad Sci USA 2002; 99: 13031-6.
29. Cederbom L, Hall H, Ivars F. CD4 + CD25 + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30: 1538-43.
30. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-10.
31. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
32. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4 + CD25 + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-40.
33. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification ond functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285-94.
34. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25 + CD4 + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969-80.
35. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31: 1247-54.
36. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated ond apoptosis-prone population. Eur J Immunol 2001; 31: 1122-31.
37. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulotory properties from human blood. J Exp Med 2001; 193: 1303-10.
38. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta 1 production and responsiveness. J Exp Med 2002; 196: 237-46.
39. Asseman C, Mouze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
40. Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun 2001; 16: 115-23.
41. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002; 196: 255-60.
42. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 2002; 196: 247-53.
43. Xu H, Banerjee A, Dilulio NA, Fairchild RL. Development of effector CD8 + T cells in contact hypersensitivity occurs independently of CD4 + T cells. J Immunol 1997; 158: 4721-8.
44. Gocinski BL, Tigelaar RE. Roles of CD4 + and CD8 + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990; 144: 4121-8.
45. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D, Revillard JP, Nicolas JF. Major histocompatibility complex class I-restricted CD8 + T cells and class II-restricted CD4 + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995; 25: 3006-10.
46. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8 + T cells ond interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4 + T cells. J Exp Med 1996; 183: 1001-12.
47. Desvignes C, Bour H, Nicolas JF, Kaiserlian D. Lack of oral tolerance but oral priming far contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II- deficient mice and in CD4 + T cell-depleted mice. Eur J Immunol 1996; 26: 1756-61.
48. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, Hahne M, Kagi D, Kaiserlian D, Nicolas JF. Cytotoxicity is mondatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 1999; 189: 779-86.
49. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D, Kaneko F, Nicolas JF. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8 + Tc1 cells inducing keraticyte apoptosis. J Immunol 2002; 168: 3079-87.
50. Gorbachev AV, Fairchild RL. Regulatory role of CD4 + T cells during the development af contact hypersensitivity responses. Immunol Res 2001; 24: 69-77.
51. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4 + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000; 114: 295-302.
52. Ruckert R, Brandt K, Hafmann U, Bulfone-Paus S, Paus R. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo. J Invest Dermatol 2002; 119: 370-6.